Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Detection of minor drug-resistant populations by parallel allele-specific sequencing

A Corrigendum to this article was published on 01 February 2007

This article has been updated

Abstract

We developed a highly sensitive parallel allele-specific sequencing (PASS) assay to simultaneously analyze a large number of viral genomes and detect minor drug-resistant populations at 0.1–0.01% levels. Using this assay on samples from individuals infected with human immunodeficiency viruses (HIV), we successfully detected and quantified minor populations of drug-resistant viruses and performed linkage analysis of multiple-drug resistance mutations. This assay may serve as a useful tool to study drug resistance in HIV and other infectious agents.

NOTE: In the supplementary information initially published online to accompany this article, the image for patient 200371 in Supplementary Figure 6 was incorrect. This panel was replaced. The error has been corrected online.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Purchase on Springer Link

Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Detection of minor drug-resistance populations by PASS.
Figure 2: Detection of drug-resistance mutations in patient plasma samples by PASS.

Similar content being viewed by others

Change history

  • 18 January 2007

    In the supplementary information initially published online to accompany this article, the image for patient 200371 in Supplementary Figure 6 was incorrect. This panel was replaced. The error has been corrected online.

References

  1. Johnson, V.A. et al. Top. HIV Med. 13, 125–131 (2005).

    PubMed  Google Scholar 

  2. Charpentier, C. et al. J. Virol. 78, 4234–4247 (2004).

    CAS  PubMed  Google Scholar 

  3. Mitra, R.D. et al. Proc. Natl. Acad. Sci. USA 100, 5926–5931 (2003).

    CAS  PubMed  Google Scholar 

  4. Zhu, J., Shendure, J., Mitra, R.D. & Church, G.M. Science 301, 836–838 (2003).

    CAS  PubMed  Google Scholar 

  5. Hirsch, M.S. et al. Clin. Infect. Dis. 37, 113–128 (2003).

    PubMed  Google Scholar 

  6. Petropoulos, C.J. et al. Antimicrob. Agents Chemother. 44, 920–928 (2000).

    CAS  PubMed  Google Scholar 

  7. Van Laethem, K. et al. J. Acquir. Immune Defic. Syndr. 22, 107–118 (1999).

    CAS  PubMed  Google Scholar 

  8. Condra, J.H. et al. Nature 374, 569–571 (1995).

    CAS  PubMed  Google Scholar 

  9. Metzner, K.J. et al. J. Infect. Dis. 188, 1433–1443 (2003).

    PubMed  Google Scholar 

  10. Winters, M.A., Schapiro, J.M., Lawrence, J. & Merigan, T.C. J. Virol. 72, 5303–5306 (1998).

    CAS  PubMed  Google Scholar 

  11. Fang, G., Zhu, G., Burger, H., Keithly, J.S. & Weiser, B. J. Virol. Methods 76, 139–148 (1998).

    CAS  PubMed  Google Scholar 

  12. Liu, S.L. et al. Science 273, 415–416 (1996).

    CAS  PubMed  Google Scholar 

  13. Merritt, J., Butz, J.A., Ogunnaike, B.A. & Edwards, J.S. Biotechnol. Bioeng. 92, 519–531 (2005).

    CAS  PubMed  Google Scholar 

  14. Butz, J.A., Yan, H., Mikkilineni, V. & Edwards, J.S. BMC Genet. 5, 3 (2004).

    PubMed  Google Scholar 

  15. Shendure, J. et al. Science 309, 1728–1732 (2005).

    CAS  Google Scholar 

Download references

Acknowledgements

We thank Z. Camacho, A. Meade, B. Fee and X. Cao for their excellent technical assistance, J. Kirchherr for artwork, K. McGee for help in obtaining samples and clinical data, and B. Haynes for critical reading of the manuscript. This work was supported by grants from the US National Institutes of Health (RO1 GM 065057 to F.G. and K24 AI 01744 to J.A.B.), AIDS Clinical Trials Group (AI 136156 to J.A.B.), International Studies of AIDS-associated Co-infections (U01 AI062563 to J.A.B.), and Center for AIDS Research (P30 AI64518 to J.A.B. and F.G.).

Author information

Authors and Affiliations

Authors

Contributions

F.C. and H.C. performed experiments and analyzed data; C.B.H. and J.A.B. provided samples, analyzed data and prepared the manuscript; J.Z. designed experiments and prepared the manuscript; F.G. conceived the project and prepared the manuscript.

Corresponding author

Correspondence to Feng Gao.

Ethics declarations

Competing interests

A patent application has been filed in the US for the parallel allele-specific sequencing (PASS) assay (inventors, F.G. and J.Z.).

Supplementary information

Supplementary Fig. 1

Schematic presentation of the parallel allele-specific sequencing (PASS) assay.

Supplementary Fig. 2

Detection of minor drug-resistance mutations by PASS.

Supplementary Fig. 3

Determination of primary drug-resistance mutations in the same viral genome by sequential PASS assays.

Supplementary Fig. 4

Detection of single base mutations among diverse HIV-1 subtypes and recombinants.

Supplementary Fig. 5

Determination of sensitivity of the PASS assay.

Supplementary Fig. 6

Detection of multiple drug-resistance mutations in a patient plasma sample.

Supplementary Table 1

Detection of the A to G mutation in the M184V codon.

Supplementary Methods

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cai, F., Chen, H., Hicks, C. et al. Detection of minor drug-resistant populations by parallel allele-specific sequencing. Nat Methods 4, 123–125 (2007). https://doi.org/10.1038/nmeth995

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nmeth995

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing